Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 74 (HNRNPA1P74)

Target
HNRNPA1P74
Molecular classification
Other, Pseudogene
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 74 (HNRNPA1P74) is classified as a pseudogene, specifically a non-coding genomic region originating from the parent gene *HNRNPA1*. Pseudogenes are typically non-functional remnants of genes that have lost their ability to encode functional proteins due to mutations or truncations[1][3][4]. While some pseudogenes can have regulatory roles at the RNA level (such as acting as competitive endogenous RNAs or producing regulatory RNAs in some contexts[5]), there is no evidence that HNRNPA1P74 has such a function. HNRNPA1P74 does not encode a protein, is not a known drug target, and has no recognized physiological or disease association distinct from its parent gene, **HNRNPA1**, which itself is an RNA-binding protein involved in splicing and found to be important in several cancers[2]. Therefore, HNRNPA1P74 should not be considered a bona fide molecular target for therapeutic, diagnostic, or functional studies.

02

Biological functions

Currently, no direct biological function confirmed for HNRNPA1P74 itselfGeneral roles for pseudogenes (non-coding, possible regulatory RNA roles[5])
03

Disease associations

No direct disease role confirmed for HNRNPA1P74General: Some pseudogenes can be involved in cancer or other disease processes at the RNA level, but this is not established for HNRNPA1P74 specifically[5]

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 74 (HNRNPA1P74).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 74 (HNRNPA1P74).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call